RE: Rns27 Jul 2023 12:30
MY take is simple, awful numbers , acquisitions the way forward for now
and revenue will be many many multiples.
Burn rate , I expect substantial sums spent on litigation and due diligence , don't believe Yourgene is the only target and other companies will have been looked at in a comparison exercise. Again there will be upheaval as integration occurs but H1 2024 should be many multiples of what we were shown today.
I don't think Rees or JM cut the mustard as a CEO , hopefully a suitable one may be attracted after a few acquisitions and the successful resolution of the millstone round our necks.
Funny both RNS's issued same day. Ever get the feeling that perhaps all this started prior to May , I do , no proof , have worked on several M&A
Projects as the buyer ( not me the bank I worked for ) and the accounts going back several years wouldn't have been examined in a few weeks , never mind everything else , including synergies , premises , salary comparisons , potential redundancies, clients blah .